Successful use of BPL Factor X concentrate in a child with severe factor X deficiency

1. Brown DL, Kouides P Diagnosis and treatment of inherited factor X deficiency. Haemophilia 2008; 14: 1176P8210.1111/j.1365-2516.2008.01856.x19141158Open DOISearch in Google Scholar

2. Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost 2009; 35Q4R: 407U415.10.1055/s-0029-122576319598069Open DOISearch in Google Scholar

3. European Medicines Agency: PrePauthorisation evaluation of medicines for human use. Public summary of positive opinion for orphan designation of human coagulation factor X for the treatment of hereditary factor X deficiency. Doc Ref: EMEA/COMP/138276/2008. Available at http://www.emea.europa.au. Accessed 20/12/11TSearch in Google Scholar

4. Auerswald G. Prophylaxis in rare coagulation disorders U factor X deficiency. Thromb Res 2006; 118Qs1R: s29P31.10.1016/j.thromres.2006.01.01516574201Search in Google Scholar

5. A Study Investigating Treatment Factor X in People With Factor X Deficiency. www.clinicaltrials.govS Accessed 26/04/2014T.Search in Google Scholar

6. UK Muscular Dystrophy Campaign. MDC1A fact sheet. Available from www.muscularPdystrophy.orgQ accessed 10/04/2014R.Search in Google Scholar